What does NeuroBo Pharmaceuticals, Inc. do?

Jun 22 2025 07:02 PM IST
share
Share Via
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing treatments for neurodegenerative disorders, with a market cap of $13.56 million and a recent net profit of -$4 million. The company is classified as a micro-cap and has no dividend yield.
Overview:
NeuroBo Pharmaceuticals, Inc. is a clinical-stage biotechnology company focused on developing pharmaceuticals to treat neurodegenerative disorders, operating within the Pharmaceuticals & Biotechnology industry and classified as a micro-cap company.

Financial Snapshot:
Most recent Net Profit: -4 Million (Quarterly Results - Mar 2025)
Market cap: USD 13.56 Million (Micro Cap)

Key Metrics:
P/E: NA (Loss Making)
Industry P/E: NA
Dividend Yield: 0.00%
Debt Equity: -2.54
Return on Equity: -570.84%
Price to Book: 3.09

Contact Details:
Address: 200 BERKELEY ST., FL 19, BOSTON MA: 02116
Tel: ['1 857 7029600', '1 917 6336086']
Fax: 1 734 2930444
Website: https://www.neurobopharma.com/
{{stockdata.stock.stock_name.value}} Live

{{stockdata.stock.price.value}} {{stockdata.stock.price_difference.value}} ({{stockdata.stock.price_percentage.value}}%)

{{stockdata.stock.date.value}} | BSE+NSE Vol: {{stockdata.index_name}} Vol: {{stockdata.stock.bse_nse_vol.value}} ({{stockdata.stock.bse_nse_vol_per.value}}%)


Our weekly and monthly stock recommendations are here
Loading...
{{!sm.blur ? sm.comp_name : ''}}
Industry
{{sm.old_ind_name }}
Market Cap
{{sm.mcapsizerank }}
Date of Entry
{{sm.date }}
Entry Price
Target Price
{{sm.target_price }} ({{sm.performance_target }}%)
Holding Duration
{{sm.target_duration }}
Last 1 Year Return
{{sm.performance_1y}}%
{{sm.comp_name}} price as on {{sm.todays_date}}
{{sm.price_as_on}} ({{sm.performance}}%)
Industry
{{sm.old_ind_name}}
Market Cap
{{sm.mcapsizerank}}
Date of Entry
{{sm.date}}
Entry Price
{{sm.opening_price}}
Last 1 Year Return
{{sm.performance_1y}}%
Related News
How big is NeuroBo Pharmaceuticals, Inc.?
Jun 22 2025 06:14 PM IST
share
Share Via